LifePoint Health (LPNT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Cantor Fitzgerald Reiterates Neutral on LifePoint Health (LPNT) After Adjusting Estimates
February 21, 2017 7:00 AM ESTCantor Fitzgerald reiterated a Neutral rating and $55.00 price target on LifePoint Health (NASDAQ: LPNT) after adjusting estimates. Cantor raised full year 2017 adjusted EPS estimates to $4.10 from $4.00, vs. the $4.13 consensus and the $4.05-$4.34 guidance. Cantor also raised adjusted EBITDA to $778 million (from $745 million) vs. the $803... More



